Latest filing published 06 Feb 2025 for Revance Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Erica Jordan: trading record in brief
Erica Jordan is a declared insider of Revance Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 16 April 2024 and the latest from 6 February 2025.
On the market, this insider has only sold: 1 sale, €8,564 in total.
The newest entry dates from 6 February 2025: a transaction, in Revance Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Erica Jordan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 107,942 sharesCommon StockSEC:0000950170-25-015356:1
- 6,922 shares@ US$3.6574.1% of flowCommon StockSEC:0000950170-25-015356:0
- 2,392 shares@ US$3.802825.9% of flowCommon StockSEC:0001479290-24-000074:0
3 of 3 declarations
